Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Elamipretide for Sale > Safe and effective SS-31 cas736992-21-5 99% purity
Safe and effective SS-31 cas736992-21-5 99% purity buy - large image1
Safe and effective SS-31 cas736992-21-5 99% purity buy - image1
Safe and effective SS-31 cas736992-21-5 99% purity buy - image2
Safe and effective SS-31 cas736992-21-5 99% purity buy - image3
Safe and effective SS-31 cas736992-21-5 99% purity buy - image4
Safe and effective SS-31 cas736992-21-5 99% purity buy - image5
Safe and effective SS-31 cas736992-21-5 99% purity buy - image6

Safe and effective SS-31 cas736992-21-5 99% purity

102 Inquiries

Unit Price: Get Latest Price
CAS No.:

736992-21-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

tianjin

Brand:

tengchu

Packaging:

5mg/box,10mg/box

Price valid (until):

2024-07-11

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Average Lead Time:
5 days
Qualification:
Main Products:

ghk-cu,Semaglutide,tirzepatide,Retatrutide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Contact me 

    Email: tengchu03@zhuanjinbio.com

    whatsapp:+852 9444 5081


    Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 1 Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 2 Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 3


     

      Specification  

     


    item value
    Other Names SS-31
    Place of Origin China

    ShanDong
    Appearance powder
    Brand Name XinLi
    Application Cosmetic Raw Materials
    Shelf life 2 Years
    Sample Avaliable
    MOQ 1 box



     

      Company profile

     


    Qingdao Xinli Technology Development Co., Ltd.address is in Qingdao, and the service is good.      Our customers come from different countries, such as the United States, Europe, Japan, Korea, India and so on.       The company is committed to the separation, purification and chiral separation of high purity natural products, as well as the development, production and marketing of API intermediates.    The company mainly engaged in high-end monomer products of natural medicinal plants, semi-synthetic derivatives of medicinal plant ingredients, chemical synthetic products, high-end natural food and cosmetic additives.    The company is a research and development and innovation as one of the high-tech Co., LTD.      Years of technology research and development, with excellent design concept to meet customer needs, to provide customers with differentiated products.


    Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 5
    Shop Safe and effective Peptides IGF-1LR3 Powder CAS 946870-92-4 IGF1-Detailed Image 6



     

      FAQ


    Q:Can we print our logo on the product?

    A:Of course, we can do it. Just send us your logo design.


    Q:How about the price? Can you make it cheaper?

    A:We always take the customer's benefit as the top priority. Price is negotiable under different conditions, we are assuring you to get the most competitive price.


    Q:Do you offer free samples?

    A:A 5Stars Review=A Free Sample It's appreciated that you could write us positive reviews if you like our products and service, we will offer you some free samples on your next order.


    Q:How Can I place an order?

    A:You could directly place an order via Alibaba, and sure you could just send us inquiry to any of our sales representatives to get detailed order information, and we will explain' the detail process.

    ECHEMI Editorial Reference
    Elamipretide has been used in trials studying the treatment of Leber's Hereditary Optic Neuropathy.
    Elamipretide, also known as MTP 131, is a mitochondria-targeted peptide antioxidant. Elamipretide decreases inflammation and protect against a variety of neurological illnesses. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice. Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.
    Elamipretide Synthetic is a single, non-glycosylated polypeptide chain containing 4 amino acids, having a molecular mass of 640 Dalton and a Molecular formula of C32H49N9O5 .

    Basic Info
    Product Name:

    Elamipretide

    Other Name:

    D-Arginyl-2,6-diMethyl-L-tyrosyl-L-lysyl-L-phenylalaninaMide;Elamipretide;L-Phenylalaninamide, D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-;Elamipretide (TFA salt);SS-31;MTP-131;BENDAVIA;Bendavia);Elamipretide (SS-31;ELAMIPRETIDE, >99%

    CAS No.:

    736992-21-5

    Molecular Formula:

    C32H49N9O5

    InChIKeys:

    SFVLTCAESLKEHH-WKAQUBQDSA-N

    Molecular Weight:

    639.79

    Exact Mass:

    639.38566570

    EC Number:

    205-858-1

    UNII:

    87GWG91S09

    DSSTox ID:

    DTXSID50471988

    Color/Form:

    White to Off-White

    Characteristics
    Density:

    1.34±0.1 g/cm3(Predicted)

    PKA:

    10.10±0.25(Predicted)

    Research
    Class:

    Mitochondria-targeted tetrapeptide (Szeto-Schiller peptide)

    Status:

    FDA-approved (Forzinity) — Accelerated Approval 2025

    Mechanism:

    A cell-permeable, synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates in the inner mitochondrial membrane and reversibly binds to cardiolipin, a phospholipid essential for electron transport chain (ETC) function. By stabilizing cardiolipin, SS-31 restores mitochondrial bioenergetics, reduces cytochrome c peroxidase activity, and prevents oxidative damage in cells with impaired mitochondrial function.

    Activity note:

    SS-31 does not act via traditional receptor agonism. It binds cardiolipin with high selectivity in the inner mitochondrial membrane. Functional EC₅₀ values are context-dependent (cell type, stress model). Key electrophysiology studies report mitochondrial membrane potential restoration at nanomolar concentrations.

    Source:

    Szeto HH, et al. AAPS J. 2006;8(2):E277-E283. Birk AV, et al. J Am Soc Nephrol. 2014;25(6):1157-1169.DOI

    Clinical Development:

    NCT03098797; NCT02814097; NCT02976038; NCT03354065

    FDA:

    Forzinity (approved 2025-09-19)

    References
    ChEMBL:

    CHEMBL3833370

    DrugBank:

    DB11981

    KEGG DRUG:

    D10925

    PubChem:

    PubChem

    Disclaimer:

    Elamipretide (Forzinity) is FDA-approved under accelerated approval for Barth syndrome. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    ghk-cu,Semaglutide,tirzepatide,Retatrutide

    Location:

    Room 68-5-501, Lianqiang Residential Area, No. 371 Union Road, Union Street, Xinhua District, Shijiazhuang City, Hebei Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    5 days

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    5-10

    Year of Establishment:

    2022

  • Inquiry History
    102 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    SS-31 (Elamipretide MTP-131) CAS 736992-21-5 99% White Powder XO

    10  Oct 22, 2023
    United States

    SS-31

    500 MG Feb 20, 2026
    Philippines

    Elamipretide

    100 MG Mar 17, 2026
    Philippines

    Elamipretide / SS-31

    5 G Mar 16, 2026
    Kazakstan

    SS-31

    500 MG May 22, 2026
    United States

    SS31

    30 MG Sep 20, 2026
    Australia

    Ss-31 (Elamipretide)

    1000 PCS Sep 16, 2026
    United States

    SS-31

    50 MG Sep 8, 2026
    United States

    SS31

    10 MG Aug 28, 2026
    Australia

    SS-31

    30 MG Aug 24, 2026
    Brazil

    SS-31 Lyophilized Powder

    0.1 G Jul 9, 2026
    India

    Elamipretide

    1 G Jun 23, 2026
    France

    Elamipretide

    3 G Jun 19, 2026
    United States

    Elamipretide

    5 G Jun 18, 2026
    Netherlands

    ss31

    12 G Jun 8, 2026
    United States

    ss-31

    10 G May 19, 2026
    United States

    99% lypholized ss-31 Elamipretide 10mg and 20mg vials

    10 MT May 16, 2026
    United States

    Elamipretide

    200 MG Apr 27, 2026
    United States

    SS-31

    1 KG Apr 24, 2026
    United States

    ss-31

    500 MG Apr 13, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.